Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Microport Cardioflow Medtech Co., Ltd.

Clinical trials sponsored by Shanghai Microport Cardioflow Medtech Co., Ltd., explained in plain language.

Now part of MicroPort CardioFlow Medtech Corporation 2160 HKEX

A medical device company developing transcatheter heart valve products, a subsidiary of MicroPort Scientific.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New heart valve study aims to improve life for High-Risk patients

Disease control Recruiting now

This study is testing a new heart valve replacement system (VitaFlow Liberty) in 122 people with severe aortic stenosis who are too high-risk for open-heart surgery. The goal is to see how safe and effective the valve is over 12 months, focusing on preventing death and disabling …

Sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC